Relationship of plasma anti-heparin activity and platelet survival time in coronary disease
- 1 April 1980
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 99 (4) , 438-442
- https://doi.org/10.1016/0002-8703(80)90377-4
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Sulfinpyrazone in the Prevention of Cardiac Death after Myocardial InfarctionNew England Journal of Medicine, 1978
- Platelet and fibrinogen survival in coronary atherosclerosis: Response to medical and surgical therapyThe American Journal of Cardiology, 1977
- Plasma heparin neutralizing activity in coronary artery diseaseThe American Journal of Cardiology, 1976
- Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic DiseaseNew England Journal of Medicine, 1975
- Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic DiseaseNew England Journal of Medicine, 1975
- Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic DiseaseNew England Journal of Medicine, 1975
- Heparin neutralizing activity test in the diagnosis of acute myocardial infarction.Journal of Clinical Pathology, 1975
- Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.Circulation, 1975
- Antigenic and antiheparin properties of human platelet factor 4 (PF4)Blood, 1975
- Platelet Factor 4 and Adenosine Diphosphate Release during Human Platelet AggregationNature, 1969